CIK 0001490978
- Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954284541
- Phone
- +1 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | Lorton Kenneth Patrick EVP & Chief Technology Officer | Grant or award | +8,170 | 57,388 | ||
| 2023-02-09 | Lorton Kenneth Patrick EVP & Chief Technology Officer | Grant or award · Stock Option (right to buy) | +49,000 | 49,000 | ||
| 2023-02-09 | Herman Jenny SVP & Controller | Grant or award | +8,000 | 8,003 | ||
| 2023-02-09 | Herman Jenny SVP & Controller | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2023-02-09 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +84,960 | 84,960 | ||
| 2023-02-09 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +65,525 | 65,525 | ||
| 2023-02-09 | Akinsanya Karen President of R&D, Therapeutics | Grant or award · Stock Option (right to buy) | +63,270 | 63,270 | ||
| 2023-02-09 | Abel Robert Lorne | Grant or award | +10,545 | 10,545 | ||
| 2023-02-09 | Abel Robert Lorne | Grant or award · Stock Option (right to buy) | +63,270 | 63,270 | ||
| 2023-02-02 | Tran Yvonne EVP & Chief Legal Officer | Exercise or conversion | +11,731 | $2.92 | $34K | 16,862 |
| 2023-02-02 | Tran Yvonne EVP & Chief Legal Officer | Exercise or conversion | +13,269 | $3.07 | $41K | 30,131 |
| 2023-02-02 | Tran Yvonne EVP & Chief Legal Officer | Sale | −25,000 | $27.26 | $681K | 5,131 |
| 2023-02-02 | Tran Yvonne EVP & Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) | −11,731 | $2.92 | $34K | 0 |
| 2023-02-02 | Tran Yvonne EVP & Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) | −13,269 | $3.07 | $41K | 108 |
| 2023-01-04 | Farid Ramy President & CEO | Exercise or conversion | +66,886 | $1.20 | $80K | 251,318 |
| 2023-01-04 | Farid Ramy President & CEO | Sale | −66,886 | $18.28 | $1.2M | 184,432 |
| 2023-01-04 | Farid Ramy President & CEO | Exercise or conversion · Stock Option (right to buy) | −66,886 | 0 | ||
| 2022-08-18 | Porges Geoffrey Craig EVP & CFO | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2022-08-11 | Thornberry Nancy Director | Exercise or conversion | +4,950 | $11.52 | $57K | 4,950 |
| 2022-08-11 | Thornberry Nancy Director | Sale | −4,950 | $35.00 | $173K | 0 |
Page 12 of 60 · 1,192 trades